A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
Public ClinicalTrials.gov record NCT06899802. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Two-stage, Randomized, Double-blind, Dose Ranging Phase 2 Trial in Healthy Adult Participants to Investigate Optimal Dose and Dosing Regimen, and to Evaluate Safety and Immunogenicity of the Recombinant MVA-BN-WEV Vaccine
Study identification
- NCT ID
- NCT06899802
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bavarian Nordic
- Industry
- Enrollment
- 411 participants
Conditions and interventions
Conditions
Interventions
- MVA-BN-WEV Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 9, 2025
- Primary completion
- Jan 31, 2027
- Completion
- Feb 28, 2027
- Last update posted
- Sep 30, 2025
2025 – 2027
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Benchmark Research | Sacramento | California | 95864 | — |
| Lifeline Primary Care, Inc. / CCT Research | Lilburn | Georgia | 30047 | — |
| Johnson County Clin-Trials | Lenexa | Kansas | 66219 | — |
| Versailles Family Medicine, PLLC/CCT Research | Versailles | Kentucky | 40383 | — |
| Benchmark Research | Kenner | Louisiana | 70065 | — |
| Jefferson City Medical Group / Avacare | Jefferson City | Missouri | 65109 | — |
| Clay-Platte Family Medicine, P.C./CCT Research | Kansas City | Missouri | 64151 | — |
| Papillion Research Center/CCT Research | Papillion | Nebraska | 68046 | — |
| Benchmark Research | San Angelo | Texas | 76904 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06899802, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06899802 live on ClinicalTrials.gov.